Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.

about

Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma.Therapeutic effects of adenovirus-mediated CD and NIS expression combined with Na131I/5-FC on human thyroid cancer.Evaluation of PACE4 isoforms as biomarkers in thyroid cancer

P2860

Q41260523-4564AA87-D2CA-469C-8D9E-CE3EF20CD948 Q49207200-D1DF7F7B-D92B-4F5F-B10A-47BE19185F65 Q57810683-213CA0CD-D03B-462B-A2B7-ECDD00FD2BAC

P2860

Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.

Item

http://www.wikidata.org/entity/Q38243095

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.

@en

type

Item

label

Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.

@en

prefLabel

Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.

@en

P1476

Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.

@en

P2093

Linwah Yip

http://www.w3.org/2001/XMLSchema#string

P2860

Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis

RAS mutations in thyroid cancer

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer.

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]

RET/PTC rearrangement in thyroid tumors

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

P304

43-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.23768

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25155423

http://www.w3.org/2001/XMLSchema#string

Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.

about

P2860

P2860

Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698